# ORACLE INVESTMENT MANAGEMENT INC

> Institutional holdings reported to the SEC as of Q4 2025 on Form 13F. CIK 1012622. Source: https://holderbook.com/funds/1012622-oracle-investment-management-inc/

- Reported value: $167.9M
- Positions: 22
- Weight of the ten largest: 94.3%
- Filed: 2026-02-18

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| GENEDX HOLDINGS CORP | [WGS](https://holderbook.com/stocks/WGS/) | $115.1M | 884,654 | 68.5% | 11 |
| ARDELYX INC | [ARDX](https://holderbook.com/stocks/ARDX/) | $10.9M | 1,872,624 | 6.5% | 13 |
| BIOHAVEN LTD | [BHVN](https://holderbook.com/stocks/BHVN/) | $8.7M | 772,181 | 5.2% | 14 |
| TELADOC HEALTH INC | [TDOC](https://holderbook.com/stocks/TDOC/) | $4.5M | 0 | 2.7% | 5 |
| NOVAVAX INC | - | $4.0M | 0 | 2.4% | 1 |
| ARDELYX INC | [ARDX](https://holderbook.com/stocks/ARDX/) | $3.5M | 0 | 2.1% | 9 |
| QUIDELORTHO CORP | [QDEL](https://holderbook.com/stocks/QDEL/) | $3.4M | 118,291 | 2.0% | 15 |
| FORIAN INC | [FORA](https://holderbook.com/stocks/FORA/) | $2.9M | 1,366,107 | 1.7% | 20 |
| PERSONALIS INC | [PSNL](https://holderbook.com/stocks/PSNL/) | $2.7M | 339,343 | 1.6% | 2 |
| BIOHAVEN LTD | [BHVN](https://holderbook.com/stocks/BHVN/) | $2.6M | 0 | 1.6% | 11 |
| TELADOC HEALTH INC | [TDOC](https://holderbook.com/stocks/TDOC/) | $2.5M | 354,338 | 1.5% | 4 |
| TAYSHA GENE THERAPIES INC | [TSHA](https://holderbook.com/stocks/TSHA/) | $1.5M | 265,000 | 0.9% | 1 |
| CAVA GROUP INC | [CAVA](https://holderbook.com/stocks/CAVA/) | $1.0M | 17,100 | 0.6% | 8 |
| EDGEWISE THERAPEUTICS INC | [EWTX](https://holderbook.com/stocks/EWTX/) | $951.5K | 38,343 | 0.6% | 1 |
| DAY ONE BIOPHARMACEUTICALS I | [DAWN](https://holderbook.com/stocks/DAWN/) | $932.0K | 100,000 | 0.6% | 1 |
| PFIZER INC | [PFE](https://holderbook.com/stocks/PFE/) | $622.5K | 0 | 0.4% | 1 |
| ARK ETF TR | [ARKG](https://holderbook.com/stocks/ARKG/) | $564.9K | 19,500 | 0.3% | 1 |
| SANGAMO THERAPEUTICS INC | [SGMOQ](https://holderbook.com/stocks/SGMOQ/) | $435.0K | 1,035,742 | 0.3% | 2 |
| BIOGEN INC | [BIIB](https://holderbook.com/stocks/BIIB/) | $424.5K | 2,412 | 0.3% | 29 |
| TEMPUS AI INC | [TEM](https://holderbook.com/stocks/TEM/) | $384.2K | 6,507 | 0.2% | 1 |
| TESLA INC | [TSLA](https://holderbook.com/stocks/TSLA/) | $224.9K | 500 | 0.1% | 2 |
| HERTZ GLOBAL HLDGS INC | [HTZ](https://holderbook.com/stocks/HTZ/) | $77.1K | 15,000 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q4 2025 | +11.8% | +2.4% | +9.4% | 100% |
| Q3 2025 | +15.7% | +7.8% | +7.9% | 100% |
| Q2 2025 | -1.8% | +10.5% | -12.2% | 100% |
| Q1 2025 | +0.2% | -4.6% | +4.8% | 100% |
| Q4 2024 | +12.8% | +2.1% | +10.6% | 100% |
| Q3 2024 | +32.5% | +5.4% | +27.1% | 100% |
| Q2 2024 | -10.6% | +4.0% | -14.7% | 100% |
| Q1 2024 | -3.2% | +10.0% | -13.3% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2025 | $167.9M | 22 |
| Q3 2025 | $160.1M | 20 |
| Q2 2025 | $145.8M | 14 |
| Q1 2025 | $198.2M | 17 |
| Q4 2024 | $183.7M | 19 |
| Q3 2024 | $166.9M | 22 |
| Q2 2024 | $107.2M | 22 |
| Q1 2024 | $150.5M | 27 |
| Q4 2023 | $164.4M | 26 |
| Q3 2023 | $325.8M | 23 |
| Q2 2023 | $135.7M | 29 |
| Q1 2023 | $103.3M | 27 |